Multi-Targeting Bioactive Compounds Extracted from Essential Oils as Kinase Inhibitors

Molecules. 2020 May 6;25(9):2174. doi: 10.3390/molecules25092174.

Abstract

Essential oils (EOs) are popular in aromatherapy, a branch of alternative medicine that claims their curative effects. Moreover, several studies reported EOs as potential anti-cancer agents by inducing apoptosis in different cancer cell models. In this study, we have considered EOs as a potential resource of new kinase inhibitors with a polypharmacological profile. On the other hand, computational methods offer the possibility to predict the theoretical activity profile of ligands, discovering dangerous off-targets and/or synergistic effects due to the potential multi-target action. With this aim, we performed a Structure-Based Virtual Screening (SBVS) against X-ray models of several protein kinases selected from the Protein Data Bank (PDB) by using a chemoinformatics database of EOs. By evaluating theoretical binding affinity, 13 molecules were detected among EOs as new potential kinase inhibitors with a multi-target profile. The two compounds with higher percentages in the EOs were studied more in depth by means Induced Fit Docking (IFD) protocol, in order to better predict their binding modes taking into account also structural changes in the receptor. Finally, given its good binding affinity towards five different kinases, cinnamyl cinnamate was biologically tested on different cell lines with the aim to verify the antiproliferative activity. Thus, this work represents a starting point for the optimization of the most promising EOs structure as kinase inhibitors with multi-target features.

Keywords: SBVS; anti-cancer; essential oils; kinases; multi-target; polypharmacology.

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Cinnamates / pharmacology
  • ErbB Receptors / chemistry
  • Humans
  • Ligands
  • Molecular Docking Simulation
  • Oils, Volatile / analysis
  • Oils, Volatile / chemistry*
  • Polypharmacology
  • Protein Kinase Inhibitors / pharmacology*
  • Protein Kinases / chemistry*
  • Protein-Tyrosine Kinases / chemistry
  • Proto-Oncogene Proteins B-raf / chemistry
  • Pyruvate Dehydrogenase Acetyl-Transferring Kinase / chemistry
  • Receptor Protein-Tyrosine Kinases / chemistry
  • Structure-Activity Relationship

Substances

  • Antineoplastic Agents
  • Cinnamates
  • Ligands
  • Oils, Volatile
  • PDK1 protein, human
  • Protein Kinase Inhibitors
  • Pyruvate Dehydrogenase Acetyl-Transferring Kinase
  • Protein Kinases
  • BMX protein, human
  • EGFR protein, human
  • ErbB Receptors
  • Protein-Tyrosine Kinases
  • RON protein
  • Receptor Protein-Tyrosine Kinases
  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf